Market Outlook

By 2035, the U.S. Connected Patient Monitoring Devices Market is expected to reach approximately USD 69.42 billion, expanding at a CAGR of 14.20% during the forecast period from 2026 to 2035. The market was valued at an estimated USD 18.40 billion in 2025, with historical analysis covering 2021 to 2024. All values in this report are expressed in USD billions.

The market expanded from approximately USD 10.85 billion in 2021 to USD 12.20 billion in 2022, USD 13.80 billion in 2023, and USD 15.95 billion in 2024. Growth during the historical period was supported by hospital digitization, post-pandemic normalization of procedural volumes, wider adoption of remote physiologic monitoring, replacement of aging bedside monitoring infrastructure, increasing use of wearable biosensors, and the expansion of hospital-at-home and post-discharge surveillance programs.

Connected patient monitoring devices encompass clinical-grade equipment that captures physiologic data and transmits it to clinicians, centralized monitoring stations, electronic health records, mobile applications, or cloud-based care-management platforms. The market includes networked multiparameter monitors, wireless vital-sign monitors, connected blood pressure devices, pulse oximeters, electrocardiography systems, mobile cardiac telemetry devices, continuous glucose monitors, respiratory monitors, wearable biosensors, connected fetal and neonatal monitors, hemodynamic monitoring systems, and device gateways used to aggregate and route patient data.

The market definition focuses on connected medical monitoring hardware, associated sensors, connectivity modules, device-management software, and hardware-linked clinical platforms. General-purpose consumer wellness trackers without a defined medical monitoring function are excluded. Pure telehealth consultation services, standalone electronic health record systems, and care-management services without a connected device component are also outside the core market boundary.

Underlying demand is substantial. Approximately 194 million U.S. adults reported at least one chronic condition in 2023, while around 130 million reported multiple chronic conditions. Among adults aged 65 years and older, more than nine in ten have at least one chronic condition. Nearly half of U.S. adults aged 20 years or older have hypertension, while adult obesity prevalence exceeds 40%. These conditions create recurring monitoring requirements across cardiovascular care, diabetes management, respiratory disease, renal disease, post-acute recovery, and high-risk pregnancy.

The U.S. hospital system also provides a large installed base for connected monitoring. The country has more than 6,000 hospitals, approximately 913,000 staffed beds, and over 34 million annual hospital admissions. Monitoring is therefore not limited to intensive care units. Health systems are extending continuous surveillance into emergency departments, general medical-surgical floors, step-down units, ambulatory facilities, recovery areas, specialty clinics, and patients’ homes.

Medicare remote patient monitoring payments exceeded USD 500 million in 2024 and increased by approximately 31% from the previous year. This reimbursement growth does not represent the full value of the connected device market, but it demonstrates that remote monitoring has moved beyond pilot status and is becoming an established component of physician practice economics.

The market’s next growth phase will be driven by the convergence of hospital-grade sensing, wireless connectivity, clinical analytics, mobile workflows, and longitudinal care delivery. Devices capable of following patients across inpatient, ambulatory, and home settings will gain preference over isolated products that generate data without supporting clinical action.

 

Introduction

According to the U.S. Connected Patient Monitoring Devices Market Report, patient monitoring is evolving from a collection of separate bedside instruments into a connected clinical infrastructure. Physiologic data are increasingly expected to move automatically from the patient to the appropriate clinician, command center, electronic health record, or care-management workflow with minimal manual entry.

This transition is strategically important because conventional monitoring models create visibility gaps. Intensive care patients are continuously observed, but many patients on general wards receive intermittent vital-sign checks. After discharge, clinician visibility may fall sharply even though patients remain vulnerable to deterioration, medication-related complications, infection, arrhythmia, hypoxemia, fluid overload, glycemic instability, or surgical complications. Connected devices reduce these gaps by creating more frequent or continuous streams of clinically relevant data.

The market includes both capital equipment and recurring-revenue products. Bedside monitors, central stations, telemetry infrastructure, networking equipment, and clinical command-center systems create capital procurement opportunities. Sensors, electrodes, cuffs, patches, disposable leads, glucose sensors, accessories, software subscriptions, connectivity services, and replacement devices create recurring revenue.

The U.S. market is especially attractive because it combines a large chronic disease population, advanced hospital infrastructure, strong specialist networks, broad smartphone and internet access, established reimbursement for remote monitoring, active hospital-at-home programs, and a high concentration of medical device and digital health innovators.

Approximately 91% of community-dwelling Medicare beneficiaries had internet access in 2024. This does not eliminate digital access barriers, but it materially expands the population that can participate in app-supported, cellular-enabled, or gateway-based monitoring programs. Cellular devices and preconfigured monitoring kits are also helping providers reach patients who do not have reliable Wi-Fi or who may struggle with device pairing.

Hospital procurement behavior is changing accordingly. Connected monitoring platforms are no longer assessed only through sensor accuracy or device acquisition cost. Health systems increasingly evaluate total clinical and operational value, including reduction in manual documentation, alarm management, nursing workload, unplanned intensive care transfers, length of stay, avoidable readmissions, cybersecurity burden, interoperability, and scalability across multiple facilities.

From 2026 to 2035, the strongest suppliers will be those capable of supporting an end-to-end monitoring architecture. This includes accurate sensing, secure connectivity, device provisioning, data normalization, workflow integration, alert prioritization, remote maintenance, cybersecurity updates, and evidence demonstrating improved clinical or economic outcomes.

 

Key Market Drivers: What Is Fueling the U.S. Connected Patient Monitoring Devices Market Boom?

The first major driver is the growing prevalence of chronic and multimorbid disease. Hypertension, diabetes, heart failure, chronic obstructive pulmonary disease, obesity, chronic kidney disease, and cardiac arrhythmias frequently require repeated physiologic measurement rather than episodic office-based assessment. A connected blood pressure cuff, glucose sensor, pulse oximeter, weight scale, ECG patch, or multiparameter wearable can provide clinicians with a more complete view of patient status between visits.

Cardiovascular disease is particularly important to market growth. Connected ECG devices, mobile cardiac telemetry, implantable rhythm monitors, blood pressure monitors, pulse oximeters, weight scales, and hemodynamic sensors support the management of arrhythmia, hypertension, heart failure, ischemic disease, and post-procedural recovery. Cardiology also has comparatively mature remote monitoring workflows, making it one of the largest application areas.

A second driver is hospital workforce pressure. U.S. hospitals continue to face nursing shortages, high labor costs, variable staffing ratios, and increasing patient complexity. Conventional monitoring models require nurses or technicians to collect, record, verify, and interpret measurements manually. Automated data capture can reduce repetitive documentation, while centralized surveillance can help clinical teams prioritize patients requiring immediate attention.

Connected monitoring does not eliminate the need for clinical judgment. Its economic value comes from directing scarce staff capacity toward higher-value activity. Technologies that reduce manual spot checks, eliminate duplicate data entry, support mobile notification, and provide actionable trend information are therefore receiving greater attention from value-analysis committees.

A third driver is hospital capacity management. With approximately 913,000 staffed beds and more than 34 million annual admissions, even modest improvements in bed turnover, discharge timing, or intensive care utilization can generate meaningful economic value. Wearable inpatient monitors allow suitable patients to remain mobile while under surveillance. Post-discharge monitoring can provide clinicians with additional confidence when moving selected patients home earlier.

The Acute Hospital Care at Home initiative accelerated this transition. By October 2024, 366 hospitals had participated in the program and more than 31,000 patients had received hospital-level services at home. Connected monitoring is foundational to these models because clinicians require timely information on oxygen saturation, respiratory rate, heart rate, blood pressure, temperature, glucose, weight, activity, and other condition-specific measures.

A fourth driver is the maturation of remote patient monitoring reimbursement. Medicare broadly covers remote physiologic monitoring for acute and chronic conditions when applicable requirements are met. The reimbursement structure supports device setup, data transmission, clinical review, and treatment-management activity. This has encouraged physician groups, health systems, home health organizations, and specialized monitoring providers to build recurring monitoring programs.

Medicare payments for remote patient monitoring reached approximately USD 536 million in 2024, representing a 31% year-over-year increase. At the same time, federal oversight is increasing. Providers and vendors must demonstrate appropriate patient relationships, documented medical necessity, sufficient data collection, meaningful clinical interaction, and compliant billing. The next phase of adoption will therefore favor clinically integrated programs over device-distribution models that lack sustained patient management.

A fifth driver is the shift toward value-based care. Accountable care organizations, Medicare Advantage plans, integrated delivery networks, and risk-bearing physician groups have an economic interest in identifying deterioration before it results in an emergency department visit or hospitalization. Connected devices can support this objective when monitoring data are integrated with care protocols and timely intervention.

The strongest value proposition is not simply that a device produces more data. Buyers want evidence that the data can influence a decision, improve medication titration, identify a worsening condition, reduce avoidable utilization, or support a safer care transition. Manufacturers increasingly need to demonstrate clinical outcomes and workflow economics rather than relying on technical specifications alone.

A sixth driver is the expansion of decentralized specialty care. Cardiology, endocrinology, pulmonology, nephrology, oncology, obstetrics, and post-surgical care are all adopting remote or hybrid monitoring models. Oncology programs can monitor symptoms, temperature, weight, oxygenation, and activity between treatment cycles. Maternity programs can use connected blood pressure devices to identify hypertensive complications. Pulmonary programs can follow oxygen saturation, respiratory rate, spirometry, and adherence to therapy.

A seventh driver is the development of reliable cellular and low-friction devices. Early remote monitoring programs frequently experienced pairing difficulties, connectivity failures, password problems, and patient onboarding challenges. Newer devices can arrive preconfigured, transmit data through embedded cellular connections, and require limited interaction from the patient. This is especially important for older adults, rural populations, and patients with limited digital literacy.

An eighth driver is the replacement cycle for hospital monitoring infrastructure. Many health systems operate mixed fleets assembled through years of acquisitions and departmental purchasing. These environments can create inconsistent alarm settings, incompatible accessories, fragmented service agreements, cybersecurity vulnerabilities, and limited enterprise visibility. System-wide modernization programs allow hospitals to standardize monitoring across facilities and connect devices to common clinical platforms.

 

Innovation in Focus: How Manufacturers Are Raising the Bar

Innovation in the U.S. connected patient monitoring devices market is increasingly directed toward mobility, interoperability, predictive capability, and continuity across care settings. The competitive benchmark is shifting from whether a device can transmit data to whether it can deliver reliable, contextualized information without increasing clinician burden.

Wearable multiparameter monitoring is one of the most important innovation areas. Adhesive patches, wrist-worn systems, chest sensors, and lightweight portable monitors can continuously capture combinations of heart rate, respiratory rate, oxygen saturation, temperature, ECG, posture, activity, and other measurements. These systems allow patients to move more freely than conventional tethered monitors and can extend surveillance to lower-acuity hospital units.

Wearable monitoring also addresses a clinical blind spot between scheduled vital-sign checks. A patient’s deterioration may begin gradually through rising respiratory rate, declining oxygen saturation, increasing heart rate, reduced activity, or altered temperature. Continuous trend monitoring can identify changes that may not be evident from isolated measurements.

Artificial intelligence and algorithmic alert prioritization represent another major innovation cycle. Continuous monitoring generates large data volumes, and poorly designed systems can overwhelm clinicians with non-actionable alerts. Manufacturers are developing algorithms that evaluate trends, combine multiple parameters, suppress artifact, and identify patterns associated with deterioration.

The commercial objective is to improve signal-to-noise performance. Hospitals do not want more alarms; they want better prioritization. Platforms that can reduce nuisance alarms while maintaining sensitivity to clinically meaningful change will have a stronger procurement case.

Hospital-to-home continuity is also becoming a central design principle. Historically, inpatient monitors and home monitoring devices were separate product categories with separate data systems. Manufacturers are now developing platforms that preserve the patient record as the individual moves from intensive care to a general ward, ambulatory recovery, and home.

This continuity can support earlier discharge, post-surgical surveillance, chronic disease stabilization, and virtual hospital programs. It also allows health systems to use a familiar dashboard, escalation protocol, or analytics layer across multiple settings.

Connectivity architecture is becoming more flexible. Hospitals may require Wi-Fi, secure medical-grade radiofrequency networks, wired Ethernet, Bluetooth, cellular transmission, or hybrid gateway systems depending on location and use case. Home programs increasingly favor cellular devices because they reduce dependence on patient-owned technology. Hospitals may favor managed wireless networks that provide high availability and centralized device control.

Interoperability with electronic health records is another major source of differentiation. Automatic transfer of validated observations can reduce transcription errors and documentation time. However, buyers increasingly expect more than one-way data transfer. They want patient matching, device association, alarm routing, trend visualization, mobile access, and integration with clinical decision-support workflows.

Standards-based connectivity, including HL7 and FHIR-enabled exchange, is helping health systems combine device data with diagnoses, medications, laboratory results, and encounter information. The strategic value lies in turning separate measurements into a longitudinal patient context.

Cybersecurity has moved to the center of product development. Connected monitoring devices may communicate with hospital networks, cloud environments, smartphones, gateways, and third-party applications. This creates potential exposure through software components, authentication weaknesses, unpatched vulnerabilities, insecure communication, and unsupported legacy operating systems.

FDA requirements for cyber devices now require manufacturers to address vulnerability management, postmarket monitoring, security updates, and software bills of materials. Hospital procurement committees are responding by evaluating patching processes, encryption, access control, network segmentation, asset visibility, support periods, and incident-response capability.

Patient monitor vulnerabilities identified by the FDA have reinforced the importance of secure-by-design development. Cybersecurity performance is becoming part of clinical reliability because a compromised or unavailable monitoring system can delay diagnosis, suppress alarms, expose patient information, or interrupt care.

Sensor innovation is also expanding the number of measurable parameters. Continuous glucose monitoring has already established the commercial value of real-time biochemical sensing. Future connected systems are likely to incorporate broader combinations of hemodynamic, metabolic, respiratory, and behavioral information. Noninvasive and minimally invasive sensing technologies capable of producing dependable clinical data will create new market categories.

Manufacturers are further differentiating through workflow design. Successful products increasingly include automated patient onboarding, preconfigured care pathways, multilingual applications, adherence prompts, supply management, clinician dashboards, escalation rules, documentation support, and device logistics. The device remains essential, but the overall workflow determines whether a monitoring program can operate efficiently at scale.

 

Segmentation Insights

The U.S. Connected Patient Monitoring Devices Market is segmented on the basis of product type, connectivity technology, application, end user, and region.

 

By Product Type

Networked Multiparameter and Bedside Monitoring Systems

Networked multiparameter and bedside monitors represent one of the largest established product categories. These systems measure combinations of ECG, heart rate, blood pressure, oxygen saturation, respiratory rate, temperature, capnography, and other parameters. They are used in intensive care units, operating rooms, emergency departments, step-down units, neonatal units, and general hospital wards.

The segment includes bedside monitors, portable monitors, central monitoring stations, telemetry receivers, transport monitors, modules, cables, sensors, and device-connectivity infrastructure. Demand is supported by hospital replacement cycles, expansion of monitored beds, standardization across integrated delivery networks, and modernization of clinical command centers.

Large hospitals increasingly prefer scalable platforms that can support high-acuity and lower-acuity settings through a common architecture. Procurement decisions depend on measurement accuracy, alarm performance, battery life, service support, cybersecurity, compatibility with existing sensors, and electronic health record integration.

Connected Cardiac and Rhythm Monitoring Devices

Connected cardiac monitoring is expected to remain a major revenue-generating category. The segment includes mobile cardiac telemetry systems, connected Holter monitors, ECG patches, handheld ECG devices, event monitors, implantable loop recorder connectivity, telemetry systems, and remote follow-up solutions for implanted rhythm devices.

Cardiac monitoring benefits from a large addressable patient population and clearly defined clinical use cases. Atrial fibrillation, unexplained syncope, palpitations, bradycardia, ventricular arrhythmias, post-ablation surveillance, and post-discharge monitoring all support demand.

The segment is moving toward longer wear duration, improved patient comfort, more efficient data processing, and faster physician access to clinically relevant events. Algorithm-supported rhythm classification can reduce review burden, although diagnostic accuracy and transparent physician oversight remain essential.

Wearable Biosensors and Patch-Based Multiparameter Devices

Wearable biosensors are among the fastest-growing product categories. These devices are designed for continuous or high-frequency monitoring without confining the patient to a bed. Products may measure heart rate, respiratory rate, oxygen saturation, temperature, ECG, activity, body position, sleep, or combinations of these parameters.

Hospitals are evaluating wearable systems for medical-surgical units, post-intensive-care surveillance, emergency department observation, post-operative recovery, and early-discharge programs. Home-based use includes chronic disease management, post-acute recovery, oncology monitoring, and hospital-at-home care.

The long-term commercial opportunity will depend on sensor reliability, adhesive performance, battery duration, patient adherence, connectivity, algorithm validation, and the ability to integrate data into existing clinical workflows. Wearables that merely generate an additional dashboard without clear workflow integration may encounter adoption resistance.

Connected Glucose and Metabolic Monitoring Devices

Connected glucose monitoring is a high-value segment supported by the scale of diabetes in the United States and the movement from episodic finger-stick testing toward continuous or near-continuous data. The segment includes continuous glucose monitors, connected blood glucose meters, smart insulin-related monitoring ecosystems, connected weight scales, and other metabolic monitoring devices.

Continuous glucose monitoring has expanded beyond intensive insulin users into broader diabetes populations and selected preventive or metabolic care programs. Integration with smartphones, clinician portals, insulin-delivery systems, and population-health platforms has increased the strategic value of glucose data.

Growth will be influenced by reimbursement, sensor affordability, pharmacy distribution, interoperability, expanded indications, and provider capacity to interpret longitudinal glucose information. Connected metabolic monitoring is also becoming relevant to obesity management as health systems and specialty practices build more structured longitudinal care models.

Connected Vital-Sign, Respiratory, Hemodynamic, and Specialty Monitors

This category includes connected blood pressure monitors, pulse oximeters, capnography systems, respiratory monitors, spirometers, temperature monitors, weight scales, hemodynamic systems, fetal monitors, neonatal monitors, neurologic monitors, and other specialty devices.

Connected blood pressure monitoring is particularly important because hypertension affects approximately half of U.S. adults. Home measurements can provide a more representative view than isolated office readings and can support medication adjustment when incorporated into a managed clinical program.

Respiratory monitoring demand is supported by chronic obstructive pulmonary disease, asthma, sleep-related breathing disorders, post-operative respiratory risk, home oxygen use, and infection-related complications. Connected oxygen saturation, respiratory rate, capnography, and spirometry can help identify deterioration or inadequate treatment response.

Maternal monitoring is an emerging opportunity, particularly for hypertensive disorders of pregnancy and post-partum surveillance. Connected blood pressure devices can extend observation after discharge, when serious complications may still occur.

 

By Connectivity Technology

Wi-Fi and Enterprise Network-Connected Devices

Wi-Fi and enterprise-networked devices account for a significant share of hospital-based connected monitoring. They allow bedside monitors, wearable devices, portable systems, and central stations to communicate within hospital infrastructure.

The technology is well suited to large health systems that maintain managed wireless networks and centralized information-security controls. Its advantages include broad coverage, high data capacity, integration with hospital systems, and support for device-location or fleet-management functions.

Adoption depends on network reliability, roaming performance, bandwidth management, device authentication, interference control, and cybersecurity. Monitoring devices must maintain connectivity as patients move between rooms or departments without losing clinically important data.

Bluetooth and Smartphone-Connected Devices

Bluetooth connectivity is widely used in home monitoring devices, wearable sensors, pulse oximeters, blood pressure monitors, glucose meters, ECG devices, and weight scales. It offers low power consumption and compatibility with smartphones, tablets, and dedicated hubs.

The primary limitation is dependence on successful pairing, application permissions, device proximity, and patient interaction. Manufacturers are addressing these issues through simplified setup, automatic reconnection, preconfigured kits, and technical-support services.

Bluetooth-connected devices are attractive for consumer-friendly and physician-prescribed programs when patients already use compatible smartphones. They are less suitable when digital literacy, phone access, or operating-system variability could undermine data transmission.

Cellular-Enabled Monitoring Devices

Cellular connectivity is one of the fastest-growing technology segments because it reduces dependence on patient-owned internet service. Devices with embedded cellular communication can transmit data automatically with limited setup.

This is valuable for Medicare populations, rural patients, post-discharge programs, and patients managing multiple chronic conditions. Cellular blood pressure cuffs, glucose meters, scales, pulse oximeters, and monitoring hubs can be distributed as preconfigured devices linked to a defined patient account.

Providers often accept a higher device or connectivity cost in exchange for improved activation, adherence, and data continuity. Continued growth will depend on network coverage, connectivity pricing, device battery performance, and support for changing wireless standards.

Proprietary Radiofrequency and Medical Telemetry Networks

Proprietary radiofrequency and telemetry networks remain important in acute-care environments. They are designed to support continuous physiologic monitoring with controlled performance, low latency, and predictable coverage.

Hospitals use these systems for ambulatory telemetry, central monitoring, and high-acuity workflows where network reliability is clinically significant. The segment benefits from long-standing installed bases and hospital familiarity but can require substantial infrastructure investment.

The competitive direction is toward greater integration with Wi-Fi, mobile devices, hospital command centers, and enterprise device-management platforms.

Hybrid Gateway, Cloud, and Edge-Connected Architectures

Hybrid architectures use combinations of Bluetooth, Wi-Fi, cellular, gateways, cloud platforms, and edge computing. A local hub may collect data from several devices, normalize it, and transmit it securely to a clinical platform.

These systems are increasingly important in hospital-at-home and multi-device chronic care programs. One patient may require a blood pressure cuff, pulse oximeter, scale, thermometer, and glucose meter. A common gateway can reduce setup complexity and create a unified data stream.

Edge processing can also support local data validation, artifact reduction, temporary data storage, and rapid alert generation when cloud connectivity is interrupted. Buyers will increasingly evaluate the resilience of the complete connectivity architecture rather than a single communication method.

 

By Application

Cardiovascular Disease and Hypertension Management

Cardiovascular monitoring represents the largest application segment. Connected devices are used for hypertension, heart failure, arrhythmia, coronary disease, stroke-risk management, post-interventional surveillance, and cardiac rehabilitation.

Hypertension creates an especially large addressable market because approximately 49% of U.S. adults aged 20 years and older have measured hypertension or use antihypertensive medication. Connected blood pressure monitoring can support diagnosis confirmation, medication titration, adherence assessment, and long-term control.

Heart failure programs commonly combine connected weight scales, blood pressure cuffs, pulse oximeters, symptom reporting, ECG devices, and implantable monitoring. The objective is to detect fluid accumulation or physiologic deterioration before hospitalization becomes necessary.

Diabetes, Obesity, and Metabolic Disease Management

Diabetes and metabolic disease represent a major connected monitoring application. Continuous glucose monitors and connected glucose meters generate longitudinal data that can inform medication use, diet, activity, and insulin management.

The obesity treatment market is creating additional monitoring requirements. Patients receiving structured weight-management treatment may use connected scales, blood pressure monitors, activity devices, glucose sensors, and symptom-tracking tools. Providers need objective data to evaluate response, adverse effects, adherence, and cardiometabolic improvement.

The segment is likely to gain value as connected metabolic devices become more integrated with pharmacy, primary care, endocrinology, and obesity-medicine workflows.

Respiratory Disease and Sleep-Related Monitoring

Respiratory applications include chronic obstructive pulmonary disease, asthma, pneumonia recovery, home oxygen management, post-operative respiratory surveillance, and sleep-related breathing disorders.

Connected pulse oximeters, respiratory-rate sensors, capnography systems, spirometers, ventilator data platforms, and wearable devices can help clinicians identify worsening oxygenation, airflow limitation, reduced activity, or treatment non-adherence.

The application is clinically attractive but requires careful interpretation because isolated oxygen saturation readings may be influenced by motion, circulation, skin characteristics, device quality, or incorrect placement. Medical-grade accuracy and clear escalation protocols are essential.

Post-Acute, Surgical, Oncology, and Hospital-at-Home Monitoring

This is one of the fastest-growing application areas. Health systems are using connected monitoring to support earlier discharge, post-operative surveillance, virtual wards, hospital-at-home care, oncology treatment, and recovery after acute illness.

Common parameters include heart rate, respiratory rate, oxygen saturation, blood pressure, temperature, weight, ECG, activity, and patient-reported symptoms. Monitoring intensity varies from daily spot measurements to continuous wearable surveillance.

Economic adoption depends on whether the program can reduce length of stay, prevent complications, avoid readmissions, or release inpatient capacity. Device companies that can help health systems design operational workflows will have an advantage over suppliers that provide hardware alone.

Maternal, Neonatal, Neurologic, and Other Specialty Monitoring

Connected monitoring is expanding in maternity care, neonatal care, neurology, renal disease, behavioral health, and other specialty areas. Remote blood pressure surveillance can help identify pregnancy-related hypertension and post-partum complications. Connected fetal and maternal monitoring may support selected high-risk pregnancy pathways under specialist supervision.

Neurologic monitoring includes ambulatory EEG, seizure-detection systems, activity sensors, fall detection, and connected devices used in rehabilitation or neurodegenerative disease management.

Renal monitoring can combine weight, blood pressure, fluid-status indicators, and treatment adherence. These applications remain smaller than cardiovascular and metabolic monitoring but provide attractive opportunities for specialized, clinically validated solutions.

 

By End User

Hospitals and Integrated Health Systems

Hospitals and integrated health systems are the largest end users by value. They purchase bedside monitors, telemetry systems, wearable inpatient devices, central stations, connectivity infrastructure, command-center technologies, and hospital-at-home kits.

Large systems frequently negotiate enterprise agreements and seek to standardize devices across multiple hospitals. Procurement decisions involve clinical engineering, nursing, physicians, information technology, cybersecurity, finance, supply chain, and value-analysis committees.

Suppliers must demonstrate reliability across the full device lifecycle, including implementation, integration, training, preventive maintenance, cybersecurity updates, accessory supply, and technical support. Enterprise compatibility can be more important than an isolated feature advantage.

Physician Practices and Specialty Clinics

Cardiology, endocrinology, primary care, pulmonology, nephrology, obstetrics, and other specialty practices are important users of connected monitoring. Their requirements differ from hospitals because they may lack dedicated monitoring command centers or large information-technology teams.

These buyers prioritize simple patient enrollment, automated data transmission, billing support, manageable alert volumes, clear reports, and electronic health record integration. Devices must fit the practice’s clinical staffing model rather than creating an additional uncompensated workload.

The segment will continue growing as remote monitoring becomes integrated into longitudinal chronic disease care.

Ambulatory Surgery Centers and Outpatient Facilities

Ambulatory surgery centers, outpatient departments, urgent-care centers, and diagnostic facilities use connected monitors for procedural sedation, recovery, short-term observation, cardiac evaluation, and patient transfer.

These facilities generally require compact, easy-to-use systems with lower infrastructure burden than large hospitals. Device portability, rapid patient setup, battery duration, automated documentation, and cost-efficient consumables are important purchasing factors.

As procedure migration continues, outpatient facilities will represent an increasingly meaningful market for portable multiparameter monitoring, connected capnography, pulse oximetry, and post-procedure monitoring.

Home Healthcare, Hospital-at-Home, and Remote Monitoring Providers

Home-based care represents the fastest-growing end-user category. It includes health-system hospital-at-home programs, home health agencies, specialized remote monitoring organizations, post-acute providers, and technology-enabled care companies.

These users require devices that can be shipped, activated, cleaned, reassigned, supported, and retrieved efficiently. Device logistics can materially affect program economics. Lost equipment, failed connections, low adherence, and technical-support calls can erode the value of otherwise effective technology.

Preconfigured cellular devices, reusable gateways, disposable wearable sensors, remote device management, and automated troubleshooting are therefore important sources of differentiation.

Skilled Nursing, Rehabilitation, and Long-Term Care Facilities

Skilled nursing facilities, rehabilitation centers, assisted-living communities, and long-term care organizations are increasingly adopting connected monitoring for high-risk residents.

These settings manage older populations with multiple chronic conditions, medication complexity, mobility limitations, and elevated risk of hospitalization. Connected vital-sign monitoring, fall detection, weight tracking, pulse oximetry, glucose measurement, and cardiac monitoring can support earlier intervention.

Adoption is influenced by staffing, reimbursement, connectivity infrastructure, workflow simplicity, and the ability to coordinate data with external physicians or hospital partners.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Connected Patient Monitoring Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional performance varies according to population growth, age distribution, chronic disease burden, health-system concentration, hospital-at-home adoption, technology investment, reimbursement mix, rural access requirements, and the availability of digital health infrastructure.

The South represented the largest regional market in 2025, with an estimated value of USD 6.81 billion. The West accounted for approximately USD 4.78 billion, followed by the Northeast at USD 3.68 billion and the Midwest at USD 3.13 billion.

The South is expected to remain the largest market through 2035, while the West is projected to gain the most share because of its technology ecosystem, rapid population growth in several states, and early adoption of decentralized care. By 2035, the South is expected to reach approximately USD 24.30 billion, the West USD 20.83 billion, the Northeast USD 13.19 billion, and the Midwest USD 11.10 billion.

South

The South is the largest regional market and includes Delaware, Maryland, the District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Mississippi, Alabama, Oklahoma, Texas, Arkansas, and Louisiana.

Regional leadership is supported by population scale, a large Medicare population, rapid metropolitan growth, high prevalence of hypertension, diabetes, obesity, heart disease, and respiratory illness, and continuing expansion of hospital networks. The South also contains substantial rural and medically underserved areas, creating demand for cellular-enabled devices and monitoring models that reduce travel requirements.

Texas is one of the most important state markets. Houston, Dallas-Fort Worth, Austin, and San Antonio contain large health systems, academic medical centers, specialty hospitals, physician networks, and technology-oriented care organizations. The state’s population scale supports broad demand for hospital monitoring, cardiac telemetry, diabetes devices, connected blood pressure monitoring, and hospital-at-home infrastructure.

Texas also illustrates the market’s dual structure. Large urban systems invest in enterprise monitoring platforms, clinical command centers, wearable inpatient surveillance, and advanced interoperability. Rural providers require simpler devices, cellular transmission, centralized specialist review, and durable equipment that can operate across large geographic distances.

Florida is another major market because of its older population and high concentration of Medicare beneficiaries. Connected cardiac, hypertension, glucose, respiratory, and post-acute monitoring are especially relevant. Large health systems in Miami, Tampa, Orlando, Jacksonville, and South Florida are building more integrated outpatient and home-based care pathways.

The state’s seasonal population and high volume of older adults create demand for devices that can support continuity when patients move between providers or locations. Companies that integrate monitoring with Medicare Advantage, cardiology, home health, and post-acute programs are well positioned.

North Carolina, Georgia, Tennessee, and Virginia are high-growth markets. North Carolina benefits from major academic systems, research organizations, a substantial life-sciences ecosystem, and fast-growing metropolitan areas. Georgia combines Atlanta’s large provider market with significant rural access needs. Tennessee has a major concentration of hospital operators and healthcare-services companies, making it influential in enterprise procurement and commercialization.

Virginia and Maryland benefit from sophisticated provider networks, federal healthcare activity, and proximity to major research institutions. The District of Columbia is a smaller device market by population but has high-acuity hospitals and policy influence.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Kentucky, West Virginia, and Oklahoma have substantial chronic disease burdens and large rural populations. These states are important for connected hypertension, heart failure, diabetes, respiratory, and post-discharge monitoring.

Infrastructure and affordability constraints can slow adoption, but they also strengthen the economic case for remote monitoring. Successful offerings in these markets must minimize patient setup requirements, support cellular transmission, and provide clear escalation workflows for geographically dispersed clinical teams.

The South is projected to grow from USD 6.81 billion in 2025 to approximately USD 24.30 billion by 2035. Growth will be supported by demographic expansion, hospital consolidation, Medicare Advantage penetration, chronic disease management, rural access initiatives, and wider implementation of hospital-at-home and virtual care programs.

West

The West represented approximately USD 4.78 billion in 2025 and is expected to be the fastest-growing regional market. It includes California, Washington, Oregon, Nevada, Arizona, New Mexico, Colorado, Utah, Idaho, Montana, Wyoming, Alaska, and Hawaii.

California is the largest state market in the region and one of the most influential connected healthcare markets in the country. It combines a large population, major academic medical centers, integrated health systems, technology companies, medical device developers, digital health investors, and experienced managed-care organizations.

California providers are important early adopters of wearable biosensors, remote monitoring platforms, artificial intelligence, cloud-connected devices, and hospital-to-home programs. The state’s technology ecosystem facilitates partnerships between health systems, device manufacturers, software companies, and telecommunications providers.

The market is not uniform across California. Los Angeles, San Diego, the San Francisco Bay Area, Sacramento, and Orange County support high-value enterprise opportunities. Rural northern and inland areas require scalable monitoring models capable of extending specialist access.

Arizona and Nevada are major growth markets because of rapid population expansion and increasing older-adult populations. Demand is rising for cardiac rhythm monitoring, blood pressure devices, glucose sensors, respiratory monitoring, and post-acute care technologies. Phoenix, Tucson, Las Vegas, and Reno are expanding hospital and specialty-care capacity.

Washington and Oregon have strong integrated health systems and high adoption of digital clinical workflows. Seattle is particularly important because of its technology workforce, academic research, and concentration of innovative healthcare organizations. Providers in these states frequently evaluate connected monitoring through population-health, access, and patient-experience objectives.

Colorado and Utah have growing metropolitan populations, sophisticated health systems, and active digital health ecosystems. Denver, Boulder, Salt Lake City, and surrounding markets support adoption of connected chronic care, virtual specialty programs, and hospital-at-home models.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but strategically relevant because of geographic dispersion. Connected monitoring can support patients who live far from specialty facilities or face difficult travel conditions. Cellular coverage, satellite-supported connectivity, device durability, and local clinical partnerships are particularly important in these states.

Alaska and Hawaii require distinctive logistics. Device shipment, technical support, replacement inventory, and connectivity resilience can determine whether a program is commercially sustainable. Vendors that design operations around these realities can establish defensible regional positions.

The West is expected to increase from USD 4.78 billion in 2025 to approximately USD 20.83 billion in 2035. Growth will be driven by wearable monitoring, artificial intelligence, health-system technology partnerships, hospital-to-home care, consumer familiarity with connected devices, and the continued expansion of Arizona, Nevada, Colorado, and Utah.

Northeast

The Northeast accounted for approximately USD 3.68 billion in 2025. The region includes New York, Pennsylvania, New Jersey, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont.

The Northeast is one of the most clinically sophisticated markets. It has a high concentration of academic medical centers, specialist physicians, medical schools, research institutions, teaching hospitals, and complex-care programs. Connected monitoring technologies often enter the region through clinical trials, innovation partnerships, and high-acuity hospital use cases.

New York is the largest state market in the region. New York City has major health systems and substantial demand for enterprise monitoring, telemetry, wearable inpatient surveillance, cardiac monitoring, and post-discharge programs. The state also has large suburban and upstate populations that create different requirements.

Upstate New York presents opportunities for remote specialty care, chronic disease monitoring, and regional command-center models. Vendors must therefore address both dense urban systems and geographically dispersed provider networks.

Pennsylvania is another major market, supported by large health systems in Philadelphia, Pittsburgh, Hershey, and surrounding regions. The state has strong cardiology, oncology, academic medicine, and post-acute care infrastructure. Connected monitoring is being evaluated as part of capacity management, chronic disease care, and health-system integration.

Massachusetts is highly influential despite its smaller population. Boston’s academic hospitals, life-sciences ecosystem, medical device companies, and digital health innovators make the state an important evidence-generation and early-adoption market. Products adopted by leading Massachusetts institutions can gain national visibility.

New Jersey and Connecticut provide dense hospital, physician, pharmaceutical, and life-sciences markets. Their proximity to New York and major research centers supports adoption of sophisticated monitoring technologies. Both states also have large suburban populations suitable for home-based chronic care and post-acute monitoring.

Maine, New Hampshire, and Vermont are smaller but important rural monitoring markets. Aging populations, travel distances, winter access challenges, and specialist shortages strengthen the case for connected cardiovascular, respiratory, and metabolic monitoring. Solutions must be easy to deploy and economically viable for smaller provider organizations.

Rhode Island is a compact market with concentrated health-system purchasing. Its size can support coordinated statewide or system-wide implementation when clinical and financial alignment is present.

The Northeast is expected to grow from USD 3.68 billion in 2025 to approximately USD 13.19 billion by 2035. Its growth rate is likely to remain below the West because of slower population expansion and a mature hospital base. However, it will remain one of the highest-value regions for advanced platforms, clinical trials, enterprise integration, and specialty monitoring.

Midwest

The Midwest represented approximately USD 3.13 billion in 2025. It includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota, and South Dakota.

The region provides a stable market built around major academic systems, large nonprofit hospital networks, community hospitals, rural referral centers, and a significant medical technology manufacturing base. Chronic cardiovascular, metabolic, and respiratory disease burdens support recurring demand.

Illinois is the largest Midwestern state market. Chicago contains major academic medical centers, integrated health systems, specialty practices, and a diverse patient population. The state supports enterprise monitoring modernization, cardiac telemetry, post-acute surveillance, and remote chronic care.

Ohio has a high concentration of influential health systems and specialty centers. Cleveland, Columbus, Cincinnati, and other metropolitan markets provide substantial demand for cardiac, neurologic, metabolic, and hospital monitoring. Ohio institutions are also important evaluators of new clinical technologies.

Michigan supports significant monitoring demand through large health systems in Detroit, Ann Arbor, Grand Rapids, and other markets. Cardiovascular disease, diabetes, post-acute care, and hospital capacity management are important applications.

Minnesota is strategically important because of its medical technology ecosystem, clinical research institutions, and history of innovation in patient monitoring and cardiovascular devices. The state is likely to remain an important development, partnership, and early-commercialization market.

Wisconsin, Indiana, and Missouri have established hospital networks and growing adoption of virtual care. Milwaukee, Madison, Indianapolis, St. Louis, and Kansas City are important metropolitan markets for connected inpatient and outpatient monitoring.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have lower population density and large rural areas. Remote monitoring can help regional systems manage patients across broad service areas, but program economics must reflect smaller patient volumes and limited staffing.

Cellular-enabled blood pressure monitors, scales, pulse oximeters, glucose devices, and cardiac monitoring systems are especially relevant. Centralized nursing teams or specialist hubs can support multiple rural locations when data and escalation workflows are standardized.

The Midwest is expected to grow from USD 3.13 billion in 2025 to approximately USD 11.10 billion by 2035. The region may not match the growth rate of the West or South, but it will remain attractive because of stable hospital demand, strong integrated delivery networks, medical technology expertise, and clear rural monitoring requirements.

 

Key Market Players

The U.S. Connected Patient Monitoring Devices Competitive Landscape is moderately consolidated in hospital monitoring but more fragmented in wearable devices, remote monitoring, specialty sensing, and care-at-home technology.

Large medtech companies compete through installed hospital fleets, enterprise contracts, service networks, interoperability, clinical engineering relationships, and broad sensor portfolios. Specialized companies compete through device miniaturization, proprietary algorithms, patient-friendly design, condition-specific data, cellular deployment, and faster innovation cycles.

Competition is shifting from individual devices toward integrated monitoring ecosystems. Health systems increasingly want one architecture that can acquire data from multiple sensors, associate each device with the correct patient, route information securely, support mobile workflows, integrate with electronic health records, and maintain continuity across care settings.

Some of the key players in the U.S. Connected Patient Monitoring Devices industry are:

GE HealthCare
Philips Healthcare
Medtronic
Abbott Laboratories
Masimo
Baxter International and Hillrom
Nihon Kohden
Mindray North America
Siemens Healthineers
Edwards Lifesciences
Boston Scientific Corporation
ZOLL Medical Corporation
Spacelabs Healthcare
iRhythm Technologies
DexCom
ResMed
OMRON Healthcare
BioIntelliSense
VitalConnect
AliveCor
Nonin Medical
Withings Health Solutions
Current Health, a Best Buy Health company
BIOTRONIK
Vivalink

GE HealthCare, Philips, Baxter-Hillrom, Nihon Kohden, Mindray, Masimo, and Spacelabs are major competitors in hospital patient monitoring, central stations, vital-sign systems, telemetry, and connectivity. Their installed bases and service capabilities create strong barriers to entry.

Medtronic, Abbott, Boston Scientific, BIOTRONIK, iRhythm, AliveCor, and ZOLL are important in connected cardiac monitoring, implanted-device follow-up, ECG, arrhythmia detection, and mobile cardiac telemetry.

DexCom, Abbott, OMRON, Withings, ResMed, and Nonin address high-volume home monitoring categories such as glucose, blood pressure, respiratory status, oxygen saturation, sleep-related conditions, and connected chronic disease management.

BioIntelliSense, VitalConnect, Vivalink, and Current Health represent the expansion of wearable and hospital-to-home monitoring. These companies compete through multiparameter sensing, device orchestration, remote care workflows, and integration with health-system monitoring programs.

Market share through 2035 will depend on clinical evidence, measurement accuracy, interoperability, cybersecurity, hospital contracting, recurring sensor economics, patient adherence, logistics, reimbursement alignment, and the ability to reduce clinician workload.

 

Recent Developments

Recent developments in the U.S. Connected Patient Monitoring Devices Market demonstrate a clear movement toward wearable monitoring, hospital-to-home continuity, stronger regulatory oversight, and greater cybersecurity accountability.

In 2023, GE HealthCare received FDA clearance for Portrait Mobile, a wireless wearable monitoring system designed to continuously capture parameters including respiration rate, oxygen saturation, and pulse rate while allowing inpatient mobility. In 2024, the company received clearance for Portrait VSM, further expanding its connected patient monitoring ecosystem.

These developments are strategically important because general-care monitoring is becoming a major competitive category. Hospitals want to identify deterioration earlier without installing traditional high-acuity monitors beside every bed. Wearable and portable systems can provide an intermediate level of surveillance.

In 2024, Masimo received FDA clearance allowing its W1 medical watch to connect with the Masimo SafetyNet telemonitoring system. The combination enables continuous oxygen saturation and pulse-rate data to be shared with remote caregivers and clinician portals. The development illustrates how established hospital sensing technologies are moving into wearable and home-based formats.

Philips has continued expanding its connected monitoring strategy through integration with wearable biosensor technologies designed for general wards and home monitoring. Its approach reflects a broader industry shift toward open monitoring ecosystems that can receive data from multiple device types and preserve patient visibility across settings.

Remote patient monitoring utilization continued to expand. Medicare payments reached approximately USD 536 million in 2024, increasing by 31% from 2023. This growth confirms strong provider interest but has also increased scrutiny of billing practices and clinical program integrity.

Federal oversight has identified cases in which patients did not receive all expected components of remote monitoring. As a result, the market is likely to move toward clearer documentation, stronger ordering requirements, improved provider accountability, and better identification of the physiologic data being monitored.

Cybersecurity has become a major strategic issue. In 2025, the FDA updated its cybersecurity guidance for medical devices and reinforced expectations regarding vulnerability management, secure product development, software transparency, and postmarket updates.

The FDA also communicated cybersecurity concerns involving certain connected patient monitors. These events demonstrate that connectivity can create direct clinical risk when data are transmitted insecurely or when a device communicates unexpectedly with external systems.

A 2025 correction involving a mobile cardiac outpatient telemetry application further demonstrated the importance of software configuration, alert delivery, and postmarket surveillance. In connected monitoring, the clinical product includes not only the physical sensor but also the application, data-processing environment, notification system, and supporting operational workflow.

Hospital-at-home programs continue to strengthen demand for connected monitoring. Participating hospitals must maintain ongoing clinical oversight and report quality information. As these models mature, health systems will require more dependable device logistics, remote technical support, escalation protocols, and integration with hospital command centers.

The competitive landscape is also being shaped by partnerships between established monitoring companies and wearable technology developers. Large manufacturers can provide hospital relationships, integration, regulatory experience, and service infrastructure. Smaller innovators can contribute specialized sensors, flexible form factors, and faster development cycles.

Consolidation is expected to continue as companies seek broader device portfolios and recurring data-driven revenue. Acquisition targets are likely to include wearable biosensor developers, cardiac monitoring companies, device-connectivity platforms, cybersecurity capabilities, and specialty remote monitoring technologies.

 

Conclusion

The U.S. Connected Patient Monitoring Devices Market Size & Share is positioned to expand from approximately USD 18.40 billion in 2025 to USD 69.42 billion by 2035, reflecting a CAGR of 14.20% during the forecast period.

The market’s long-term strength is supported by the scale of chronic disease, an aging population, hospital workforce pressure, growing remote monitoring reimbursement, hospital-at-home expansion, and the need to maintain clinical visibility beyond intensive care settings.

Connected monitoring is moving from a peripheral digital health category into core care-delivery infrastructure. Hospitals and physician groups increasingly view monitoring as a continuous process extending across the inpatient stay, outpatient follow-up, chronic disease management, and home recovery.

The highest-growth opportunities will emerge in wearable multiparameter monitoring, mobile cardiac telemetry, continuous glucose monitoring, connected hypertension care, hospital-at-home devices, post-surgical surveillance, cellular monitoring, artificial intelligence-assisted deterioration detection, and interoperable device platforms.

Hospital procurement will increasingly favor suppliers that can demonstrate total workflow value. Sensor accuracy remains essential, but it is no longer sufficient. Buyers will evaluate alarm performance, nursing efficiency, electronic health record integration, cybersecurity, service reliability, device logistics, patient adherence, and economic outcomes.

The South will remain the largest regional market because of its population scale, chronic disease burden, older-adult population, and expanding hospital networks. The West will be the fastest-growing region because of its technology ecosystem, population growth, health-system innovation, and early adoption of decentralized care. The Northeast will remain a premium market for advanced clinical platforms and evidence generation, while the Midwest will provide stable hospital demand and significant rural monitoring opportunities.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Michigan, Minnesota, Washington, and Tennessee will remain strategically important for manufacturers, distributors, investors, and monitoring-platform providers.

The central commercial question is not whether more monitoring devices will become connected. Connectivity is becoming a baseline expectation. The more important questions are which devices will produce clinically actionable information, which platforms will integrate effectively into existing workflows, and which business models will demonstrate measurable value to providers and payers.

Companies that combine medical-grade sensing, dependable connectivity, interoperability, cybersecurity, patient usability, and real-world clinical evidence will define the next decade of the U.S. connected patient monitoring devices industry.

 

TABLE OF CONTENT

1. U.S. Connected Patient Monitoring Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Connected Patient Monitoring Device Manufacturers
1.6.2. Sensor, Semiconductor, Component, and Contract Manufacturing Suppliers
1.6.3. Hospitals, Health Systems, and Integrated Delivery Networks
1.6.4. Physician Practices, Specialty Clinics, and Ambulatory Care Providers
1.6.5. Home Healthcare, Hospital-at-Home, and Remote Monitoring Providers
1.6.6. Group Purchasing Organizations, Distributors, and Technology Integrators
1.6.7. Payers, Regulators, Cybersecurity Authorities, and Clinical Decision-Makers

What this section provides: This section defines the connected patient monitoring devices market boundary, research scope, methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. market is measured, categorized, and validated.

2. U.S. Connected Patient Monitoring Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Leading Product, Application, Connectivity, and End-User Segments
2.9. Regional Growth and Investment Snapshot

What this section provides: This section gives decision-makers a concise view of market size, forecast direction, leading monitoring categories, adoption drivers, competitive intensity, regional performance, and priority commercial opportunities.

3. U.S. Connected Patient Monitoring Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising Prevalence of Chronic and Multimorbid Conditions
3.1.2. Expansion of Remote Physiologic Monitoring and Reimbursement-Supported Care
3.1.3. Hospital Workforce Shortages and Demand for Automated Clinical Surveillance
3.1.4. Growth of Hospital-at-Home, Virtual Wards, and Post-Discharge Monitoring
3.1.5. Increasing Adoption of Wearable Biosensors and Wireless Monitoring Devices
3.1.6. Expansion of Value-Based Care and Readmission-Reduction Programs
3.1.7. Modernization of Hospital Monitoring Infrastructure and Clinical Command Centers
3.2. Restraints and Their Impact Analysis
3.2.1. High Device, Integration, Networking, and Implementation Costs
3.2.2. Cybersecurity, Data Privacy, and Medical Device Vulnerability Risks
3.2.3. Alarm Fatigue, Data Overload, and Clinician Workflow Burden
3.2.4. Reimbursement Compliance and Remote Monitoring Documentation Requirements
3.2.5. Interoperability Limitations Across Devices and Electronic Health Records
3.2.6. Patient Adherence, Digital Literacy, and Connectivity Barriers
3.3. Opportunities and Their Impact Analysis
3.3.1. Continuous Multiparameter Wearable Monitoring
3.3.2. Cellular-Enabled Home Monitoring Devices
3.3.3. Artificial Intelligence-Based Deterioration Prediction and Alert Prioritization
3.3.4. Connected Cardiac, Hypertension, and Heart Failure Monitoring
3.3.5. Continuous Glucose and Metabolic Monitoring Expansion
3.3.6. Maternal, Neonatal, Oncology, and Specialty Monitoring Applications
3.3.7. Rural Health, Underserved Population, and Aging-in-Place Monitoring
3.4. Challenges and Their Impact Analysis
3.4.1. Clinical Validation and Measurement Accuracy Requirements
3.4.2. Device Fleet Management and Remote Technical Support
3.4.3. Sensor Replacement, Consumable Supply, and Patient Logistics
3.4.4. Integration of Data into Actionable Clinical Workflows
3.4.5. Scaling Monitoring Programs Without Increasing Staffing Costs
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Remote Monitoring Program Economics and Return-on-Investment Analysis
3.9. Alarm Management and Clinical Escalation Workflow Analysis

What this section provides: This section explains the clinical, operational, reimbursement, technological, and commercial forces shaping connected monitoring demand, helping clients evaluate market upside, adoption barriers, and implementation risks.

4. U.S. Connected Patient Monitoring Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, Cloud Connectivity, and Artificial Intelligence
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework for Connected Monitoring Devices
4.8. CMS Remote Physiologic Monitoring Reimbursement and Coverage Landscape
4.9. HIPAA, Data Privacy, and Medical Device Cybersecurity Requirements
4.10. Import/Export Restrictions & Tariff Impact
4.11. Government Initiatives, Rural Health Programs, and Hospital-at-Home Policies
4.12. Impact of Escalating Geopolitical Tensions
4.13. Hospital Value Analysis Committee Decision Framework
4.14. Electronic Health Record and Interoperability Standards Analysis
4.15. Remote Monitoring Compliance, Billing, and Audit Risk Analysis

What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, cybersecurity, pricing, supply chain, interoperability, technology adoption, and hospital procurement dynamics.

5. U.S. Connected Patient Monitoring Devices Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Networked Multiparameter and Bedside Monitoring Systems
5.1.2.1. High-Acuity Bedside Monitors
5.1.2.2. Portable and Transport Monitors
5.1.2.3. Central Monitoring Stations
5.1.2.4. Inpatient Telemetry Systems
5.1.2.5. Connected Medical-Surgical Floor Monitors
5.1.3. Connected Cardiac and Rhythm Monitoring Devices
5.1.3.1. Mobile Cardiac Telemetry Devices
5.1.3.2. Connected Holter Monitors
5.1.3.3. ECG Patches and Event Monitors
5.1.3.4. Handheld and Smartphone-Connected ECG Devices
5.1.3.5. Implantable Cardiac Monitor Connectivity Systems
5.1.4. Wearable Biosensors and Patch-Based Multiparameter Devices
5.1.4.1. Chest-Worn Biosensors
5.1.4.2. Adhesive Multiparameter Patches
5.1.4.3. Wrist-Worn Medical Monitoring Devices
5.1.4.4. Continuous Vital-Sign Wearables
5.1.4.5. Activity, Position, and Mobility Sensors
5.1.5. Connected Glucose and Metabolic Monitoring Devices
5.1.5.1. Continuous Glucose Monitoring Devices
5.1.5.2. Connected Blood Glucose Meters
5.1.5.3. Connected Weight and Body-Composition Scales
5.1.5.4. Smart Insulin-Associated Monitoring Systems
5.1.5.5. Metabolic and Digital Biomarker Monitoring Devices
5.1.6. Connected Vital-Sign, Respiratory, Hemodynamic, and Specialty Monitors
5.1.6.1. Connected Blood Pressure Monitors
5.1.6.2. Connected Pulse Oximeters
5.1.6.3. Respiratory Rate and Capnography Monitors
5.1.6.4. Connected Temperature Monitors
5.1.6.5. Hemodynamic Monitoring Systems
5.1.6.6. Connected Fetal and Maternal Monitors
5.1.6.7. Neonatal and Pediatric Monitoring Devices
5.1.6.8. Neurologic and Other Specialty Monitoring Devices

What this section provides: This section identifies which connected monitoring device categories and subcategories are expected to generate the highest revenue contribution, recurring sensor demand, and strongest growth through 2035.

6. U.S. Connected Patient Monitoring Devices Market – By Connectivity Technology

6.1. Overview
6.1.1. Segment Share Analysis, By Connectivity Technology, 2025 & 2035 (%)
6.1.2. Wi-Fi and Enterprise Network-Connected Devices
6.1.2.1. Hospital Wi-Fi Monitoring Systems
6.1.2.2. Ethernet-Connected Monitoring Infrastructure
6.1.2.3. Enterprise Wireless Device Networks
6.1.3. Bluetooth and Smartphone-Connected Devices
6.1.3.1. Bluetooth Low Energy Devices
6.1.3.2. Smartphone-Paired Monitoring Devices
6.1.3.3. Tablet and Dedicated Hub-Connected Devices
6.1.4. Cellular-Enabled Monitoring Devices
6.1.4.1. Embedded Cellular Monitoring Devices
6.1.4.2. Cellular Remote Monitoring Kits
6.1.4.3. Cellular Home Monitoring Gateways
6.1.5. Proprietary Radiofrequency and Medical Telemetry Networks
6.1.5.1. Hospital Telemetry Networks
6.1.5.2. Dedicated Medical-Grade Radiofrequency Systems
6.1.5.3. Ambulatory Inpatient Telemetry Infrastructure
6.1.6. Hybrid Gateway, Cloud, and Edge-Connected Architectures
6.1.6.1. Multi-Device Home Monitoring Gateways
6.1.6.2. Cloud-Connected Monitoring Platforms
6.1.6.3. Edge Processing and Local Analytics Systems
6.1.6.4. Hybrid Wi-Fi, Bluetooth, and Cellular Architectures

What this section provides: This section evaluates the connectivity technologies supporting real-time and remote monitoring, including network performance, deployment requirements, patient usability, data continuity, and enterprise scalability.

7. U.S. Connected Patient Monitoring Devices Market – By Application

7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
7.1.2. Cardiovascular Disease and Hypertension Management
7.1.2.1. Hypertension Monitoring
7.1.2.2. Cardiac Arrhythmia Monitoring
7.1.2.3. Heart Failure Monitoring
7.1.2.4. Post-Cardiac Procedure Monitoring
7.1.2.5. Cardiac Rehabilitation and Secondary Prevention
7.1.3. Diabetes, Obesity, and Metabolic Disease Management
7.1.3.1. Type 1 Diabetes Monitoring
7.1.3.2. Type 2 Diabetes Monitoring
7.1.3.3. Gestational Diabetes Monitoring
7.1.3.4. Obesity and Weight-Management Monitoring
7.1.3.5. Metabolic Risk and Lifestyle Intervention Monitoring
7.1.4. Respiratory Disease and Sleep-Related Monitoring
7.1.4.1. Chronic Obstructive Pulmonary Disease Monitoring
7.1.4.2. Asthma Monitoring
7.1.4.3. Home Oxygen and Hypoxemia Monitoring
7.1.4.4. Post-Operative Respiratory Monitoring
7.1.4.5. Sleep-Related Breathing Disorder Monitoring
7.1.5. Post-Acute, Surgical, Oncology, and Hospital-at-Home Monitoring
7.1.5.1. Post-Discharge Monitoring
7.1.5.2. Post-Surgical Recovery Monitoring
7.1.5.3. Hospital-at-Home and Virtual Ward Monitoring
7.1.5.4. Oncology Treatment and Symptom Monitoring
7.1.5.5. Acute Illness Recovery Monitoring
7.1.6. Maternal, Neonatal, Neurologic, Renal, and Other Specialty Monitoring
7.1.6.1. Maternal Hypertension and Pregnancy Monitoring
7.1.6.2. Fetal and Neonatal Monitoring
7.1.6.3. Neurologic and Seizure Monitoring
7.1.6.4. Renal Disease and Fluid-Status Monitoring
7.1.6.5. Rehabilitation, Fall, and Mobility Monitoring

What this section provides: This section helps clients understand connected monitoring demand by clinical use case and prioritize applications with strong patient volumes, reimbursement relevance, care-transition value, and device innovation.

8. U.S. Connected Patient Monitoring Devices Market – By End User

8.1. Overview
8.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
8.1.2. Hospitals and Integrated Health Systems
8.1.2.1. Intensive Care Units
8.1.2.2. Emergency Departments
8.1.2.3. Medical-Surgical and Step-Down Units
8.1.2.4. Operating Rooms and Recovery Areas
8.1.2.5. Hospital Clinical Command Centers
8.1.3. Physician Practices and Specialty Clinics
8.1.3.1. Cardiology Practices
8.1.3.2. Primary Care Practices
8.1.3.3. Endocrinology and Diabetes Clinics
8.1.3.4. Pulmonology and Sleep Clinics
8.1.3.5. Obstetrics, Oncology, and Other Specialty Clinics
8.1.4. Ambulatory Surgery Centers and Outpatient Facilities
8.1.4.1. Ambulatory Surgery Centers
8.1.4.2. Hospital Outpatient Departments
8.1.4.3. Urgent Care and Observation Centers
8.1.4.4. Diagnostic and Specialty Testing Facilities
8.1.5. Home Healthcare, Hospital-at-Home, and Remote Monitoring Providers
8.1.5.1. Hospital-at-Home Programs
8.1.5.2. Remote Physiologic Monitoring Providers
8.1.5.3. Home Health Agencies
8.1.5.4. Virtual Care and Digital Health Providers
8.1.5.5. Post-Acute Home Monitoring Programs
8.1.6. Skilled Nursing, Rehabilitation, and Long-Term Care Facilities
8.1.6.1. Skilled Nursing Facilities
8.1.6.2. Inpatient Rehabilitation Facilities
8.1.6.3. Assisted-Living Communities
8.1.6.4. Long-Term Care Facilities

What this section provides: This section explains which care settings and customer groups are expected to drive device purchasing, enterprise monitoring upgrades, recurring sensor use, and remote monitoring adoption.

9. U.S. Connected Patient Monitoring Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Procurement
9.1.2.2. Department-Level Monitoring Purchases
9.1.2.3. Clinical Engineering and Information Technology Procurement
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Standardization Agreements
9.1.3.2. Enterprise Monitoring Platform Contracts
9.1.3.3. Long-Term Service and Consumable Agreements
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional Purchasing Alliances
9.1.4.3. Aggregated Device and Consumable Contracts
9.1.5. Distributor, Specialty Supplier, and Technology Integrator Sales
9.1.5.1. Medical Device Distributors
9.1.5.2. Remote Monitoring Technology Integrators
9.1.5.3. Specialty Cardiac and Home Monitoring Suppliers
9.1.6. Physician Practice, Home Monitoring, and Program-Based Procurement
9.1.6.1. Physician-Prescribed Monitoring Programs
9.1.6.2. Subscription and Device-as-a-Service Models
9.1.6.3. Home Monitoring Kit Procurement
9.1.6.4. Payer-Sponsored and Risk-Based Monitoring Programs

What this section provides: This section helps clients understand how connected monitoring devices are purchased in the U.S., including hospital contracting, IDN standardization, GPO influence, distribution models, subscriptions, and program-based procurement.

10. U.S. Connected Patient Monitoring Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Bed, Chronic Disease, and Monitoring Infrastructure Analysis
10.1.4. Regional Remote Monitoring Reimbursement and Procurement Dynamics
10.1.5. Regional Hospital-at-Home and Virtual Care Adoption Analysis

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Connected Monitoring Device Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Connected Monitoring Device Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Connected Monitoring Device Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Connected Monitoring Device Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Connectivity Technology, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify connected monitoring adoption hubs, high-value hospital markets, chronic disease demand centers, remote care opportunities, and state-level commercial priorities.

11. U.S. Connected Patient Monitoring Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Competitive Benchmarking by Product Portfolio
11.4. Competitive Benchmarking by Connectivity and Interoperability
11.5. Competitive Benchmarking by Hospital and Home Monitoring Presence
11.6. Company Profiles
11.6.1. GE HealthCare
11.6.2. Philips Healthcare
11.6.3. Medtronic
11.6.4. Abbott Laboratories
11.6.5. Masimo
11.6.6. Baxter International and Hillrom
11.6.7. Nihon Kohden
11.6.8. Mindray North America
11.6.9. Siemens Healthineers
11.6.10. Edwards Lifesciences
11.6.11. Boston Scientific Corporation
11.6.12. ZOLL Medical Corporation
11.6.13. Spacelabs Healthcare
11.6.14. iRhythm Technologies
11.6.15. DexCom
11.6.16. ResMed
11.6.17. OMRON Healthcare
11.6.18. BioIntelliSense
11.6.19. VitalConnect
11.6.20. AliveCor
11.6.21. Nonin Medical
11.6.22. Withings Health Solutions
11.6.23. Current Health, a Best Buy Health Company
11.6.24. BIOTRONIK
11.6.25. Vivalink

Note: Each company profile will include company overview, connected monitoring device portfolio, U.S. market strategy, financial positioning, hospital and home monitoring presence, connectivity capabilities, interoperability strategy, clinical evidence, regulatory updates, partnerships, and recent developments.

What this section provides: This section gives clients competitor benchmarking, market share visibility, product and connectivity positioning, innovation direction, hospital contracting intelligence, and strategic profiles of leading connected patient monitoring companies.

12. U.S. Connected Patient Monitoring Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Artificial Intelligence-Based Deterioration Prediction
12.2.2. Wearable Continuous Multiparameter Biosensors
12.2.3. Cellular-Enabled Hospital-at-Home Monitoring
12.2.4. Interoperable Cloud and Edge Monitoring Platforms
12.2.5. Noninvasive Metabolic Sensing and Digital Biomarkers
12.2.6. Contactless and Ambient Patient Monitoring
12.2.7. Digital Twin and Predictive Patient Surveillance Models
12.3. Emerging Business Trends
12.3.1. Device-as-a-Service and Subscription Models
12.3.2. Bundled Device, Software, and Clinical Service Offerings
12.3.3. Health System and Technology Company Partnerships
12.3.4. Outcome-Based and Risk-Sharing Contracts
12.3.5. Consolidation of Monitoring Dashboards and Device Fleets
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Roadmap, 2026–2035
12.7. Future Hospital, Ambulatory, and Home Monitoring Workflow Analysis

What this section provides: This section prepares clients for future technology shifts, evolving monitoring architectures, business-model changes, investment opportunities, and potential market adoption scenarios through 2035.

13. U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations

13.1. Recommendations for Connected Monitoring Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Physician Practices and Specialty Care Providers
13.4. Recommendations for Home Healthcare and Hospital-at-Home Providers
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors, GPOs, and Technology Integrators
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.9. Product Positioning and Portfolio Expansion Guidance
13.10. Reimbursement and Evidence-Generation Strategy
13.11. Cybersecurity and Interoperability Strategy
13.12. Regional and State-Level Market Entry Prioritization

What this section provides: This section converts market intelligence into actionable recommendations for product development, hospital contracting, reimbursement planning, channel expansion, regional entry, investment decisions, and competitive differentiation.

14. U.S. Connected Patient Monitoring Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Reimbursement Change Disclaimer
14.7. Technology and Cybersecurity Risk Disclaimer

What this section provides: This section clarifies the report’s scope limitations, legal boundaries, data-use terms, forecasting assumptions, and the potential impact of regulatory, reimbursement, technology, and cybersecurity changes.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Connected Patient Monitoring Devices Market: Market Definition and Scope
TABLE 3: U.S. Connected Patient Monitoring Devices Market: Research Methodology Framework
TABLE 4: U.S. Connected Patient Monitoring Devices Market: Key Assumptions
TABLE 5: U.S. Connected Patient Monitoring Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Connected Patient Monitoring Devices Market: Stakeholder Analysis
TABLE 7: U.S. Connected Patient Monitoring Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Connected Patient Monitoring Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Connected Patient Monitoring Devices Market: Market Attractiveness Index
TABLE 10: U.S. Connected Patient Monitoring Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Connected Patient Monitoring Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Connected Patient Monitoring Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Connected Patient Monitoring Devices Market: Drivers; Impact Analysis
TABLE 14: U.S. Connected Patient Monitoring Devices Market: Restraints; Impact Analysis
TABLE 15: U.S. Connected Patient Monitoring Devices Market: Opportunities; Impact Analysis
TABLE 16: U.S. Connected Patient Monitoring Devices Market: Challenges; Impact Analysis
TABLE 17: U.S. Connected Patient Monitoring Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Connected Patient Monitoring Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Connected Patient Monitoring Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Connected Patient Monitoring Devices Market: Remote Monitoring Program Economics and ROI Matrix
TABLE 21: U.S. Connected Patient Monitoring Devices Market: Alarm Management and Clinical Escalation Workflow Matrix
TABLE 22: U.S. Connected Patient Monitoring Devices Market: PESTEL Analysis
TABLE 23: U.S. Connected Patient Monitoring Devices Market: Porter’s Five Forces Analysis
TABLE 24: U.S. Connected Patient Monitoring Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 25: U.S. Connected Patient Monitoring Devices Market: Value Chain Analysis
TABLE 26: U.S. Connected Patient Monitoring Devices Market: Supply Chain Analysis
TABLE 27: U.S. Connected Patient Monitoring Devices Market: Digitalization, Cloud Connectivity and AI Impact
TABLE 28: U.S. Connected Patient Monitoring Devices Market: Application & Innovation Landscape
TABLE 29: U.S. Connected Patient Monitoring Devices Market: FDA Regulatory Framework Analysis
TABLE 30: U.S. Connected Patient Monitoring Devices Market: CMS Remote Physiologic Monitoring Reimbursement Landscape
TABLE 31: U.S. Connected Patient Monitoring Devices Market: HIPAA, Data Privacy and Cybersecurity Requirements
TABLE 32: U.S. Connected Patient Monitoring Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 33: U.S. Connected Patient Monitoring Devices Market: Government Initiatives, Rural Health and Hospital-at-Home Programs
TABLE 34: U.S. Connected Patient Monitoring Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 35: U.S. Connected Patient Monitoring Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 36: U.S. Connected Patient Monitoring Devices Market: EHR and Interoperability Standards Analysis
TABLE 37: U.S. Connected Patient Monitoring Devices Market: Remote Monitoring Compliance, Billing and Audit Risk Analysis
TABLE 38: U.S. Connected Patient Monitoring Devices Market: Product Type Snapshot, 2025
TABLE 39: Segment Dashboard; Definition and Scope, by Product Type
TABLE 40: U.S. Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 41: U.S. Connected Patient Monitoring Devices Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 42: U.S. Connected Patient Monitoring Devices Market: Networked Multiparameter and Bedside Monitoring Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Connected Patient Monitoring Devices Market: Connected Cardiac and Rhythm Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Connected Patient Monitoring Devices Market: Wearable Biosensors and Patch-Based Multiparameter Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Connected Patient Monitoring Devices Market: Connected Glucose and Metabolic Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Connected Patient Monitoring Devices Market: Connected Vital-Sign, Respiratory, Hemodynamic and Specialty Monitors Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Connected Patient Monitoring Devices Market: Connectivity Technology Snapshot, 2025
TABLE 48: Segment Dashboard; Definition and Scope, by Connectivity Technology
TABLE 49: U.S. Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 50: U.S. Connected Patient Monitoring Devices Market: Segment Share Analysis, by Connectivity Technology, 2025 & 2035 (%)
TABLE 51: U.S. Connected Patient Monitoring Devices Market: Wi-Fi and Enterprise Network-Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Connected Patient Monitoring Devices Market: Bluetooth and Smartphone-Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Connected Patient Monitoring Devices Market: Cellular-Enabled Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Connected Patient Monitoring Devices Market: Proprietary Radiofrequency and Medical Telemetry Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Connected Patient Monitoring Devices Market: Hybrid Gateway, Cloud and Edge-Connected Architectures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Connected Patient Monitoring Devices Market: Application Snapshot, 2025
TABLE 57: Segment Dashboard; Definition and Scope, by Application
TABLE 58: U.S. Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 59: U.S. Connected Patient Monitoring Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 60: U.S. Connected Patient Monitoring Devices Market: Cardiovascular Disease and Hypertension Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: U.S. Connected Patient Monitoring Devices Market: Diabetes, Obesity and Metabolic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Connected Patient Monitoring Devices Market: Respiratory Disease and Sleep-Related Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Connected Patient Monitoring Devices Market: Post-Acute, Surgical, Oncology and Hospital-at-Home Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Connected Patient Monitoring Devices Market: Maternal, Neonatal, Neurologic, Renal and Other Specialty Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Connected Patient Monitoring Devices Market: End User Snapshot, 2025
TABLE 66: Segment Dashboard; Definition and Scope, by End User
TABLE 67: U.S. Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 68: U.S. Connected Patient Monitoring Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 69: U.S. Connected Patient Monitoring Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: U.S. Connected Patient Monitoring Devices Market: Physician Practices and Specialty Clinics Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: U.S. Connected Patient Monitoring Devices Market: Ambulatory Surgery Centers and Outpatient Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Connected Patient Monitoring Devices Market: Home Healthcare, Hospital-at-Home and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Connected Patient Monitoring Devices Market: Skilled Nursing, Rehabilitation and Long-Term Care Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Connected Patient Monitoring Devices Market: Procurement Channel Snapshot, 2025
TABLE 75: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 76: U.S. Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 77: U.S. Connected Patient Monitoring Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 78: U.S. Connected Patient Monitoring Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: U.S. Connected Patient Monitoring Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: U.S. Connected Patient Monitoring Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Connected Patient Monitoring Devices Market: Distributor, Specialty Supplier and Technology Integrator Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Connected Patient Monitoring Devices Market: Physician Practice, Home Monitoring and Program-Based Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Connected Patient Monitoring Devices Market: Regional Snapshot, 2025
TABLE 84: Segment Dashboard; Definition and Scope, by Region
TABLE 85: U.S. Connected Patient Monitoring Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 86: U.S. Connected Patient Monitoring Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 87: U.S. Connected Patient Monitoring Devices Market: Regional Hospital Bed, Chronic Disease and Monitoring Infrastructure Analysis
TABLE 88: U.S. Connected Patient Monitoring Devices Market: Regional Remote Monitoring Reimbursement and Procurement Dynamics
TABLE 89: U.S. Connected Patient Monitoring Devices Market: Regional Hospital-at-Home and Virtual Care Adoption Analysis
TABLE 90: West Region U.S. Connected Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. Connected Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 92: West Region U.S. Connected Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 98: California Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 99: California Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 100: California Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 101: California Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 102: California Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 103: Washington Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 104: Washington Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 105: Washington Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 106: Washington Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 107: Washington Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 108: Arizona Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 109: Arizona Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 110: Arizona Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 111: Arizona Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 112: Arizona Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 113: Colorado Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 114: Colorado Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 115: Colorado Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 116: Colorado Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 117: Colorado Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 118: Oregon Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 119: Oregon Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 120: Oregon Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 121: Oregon Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 122: Oregon Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 123: Utah Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 124: Utah Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 125: Utah Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 126: Utah Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 127: Utah Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 128: Nevada Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 129: Nevada Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 130: Nevada Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 131: Nevada Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 132: Nevada Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 138: Idaho Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 139: Idaho Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 140: Idaho Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 141: Idaho Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 142: Idaho Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 143: Montana Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 144: Montana Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 145: Montana Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 146: Montana Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 147: Montana Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 153: Alaska Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 154: Alaska Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 155: Alaska Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 156: Alaska Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 157: Alaska Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Connected Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. Connected Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 165: Northeast Region U.S. Connected Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 171: New York Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 172: New York Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 173: New York Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 174: New York Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 175: New York Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 196: Maine Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 197: Maine Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 198: Maine Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 199: Maine Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 200: Maine Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 201: Vermont Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 202: Vermont Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 203: Vermont Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 204: Vermont Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 205: Vermont Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 216: Delaware Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 217: Delaware Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 218: Delaware Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 219: Delaware Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 220: Delaware Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Connected Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 222: South Region U.S. Connected Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 223: South Region U.S. Connected Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 229: Texas Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 230: Texas Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 231: Texas Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 232: Texas Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 233: Texas Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 234: Florida Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 235: Florida Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 236: Florida Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 237: Florida Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 238: Florida Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 239: Georgia Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 240: Georgia Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 241: Georgia Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 242: Georgia Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 243: Georgia Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 259: Alabama Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 260: Alabama Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 261: Alabama Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 262: Alabama Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 263: Alabama Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 289: Virginia Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 290: Virginia Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 291: Virginia Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 292: Virginia Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 293: Virginia Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 294: Maryland Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 295: Maryland Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 296: Maryland Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 297: Maryland Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 298: Maryland Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Connected Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 305: Midwest Region U.S. Connected Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 306: Midwest Region U.S. Connected Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 312: Illinois Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 313: Illinois Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 314: Illinois Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 315: Illinois Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 316: Illinois Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 317: Ohio Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 318: Ohio Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 319: Ohio Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 320: Ohio Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 321: Ohio Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 322: Michigan Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 323: Michigan Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 324: Michigan Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 325: Michigan Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 326: Michigan Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 332: Indiana Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 333: Indiana Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 334: Indiana Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 335: Indiana Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 336: Indiana Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 342: Missouri Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 343: Missouri Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 344: Missouri Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 345: Missouri Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 346: Missouri Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 347: Iowa Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 348: Iowa Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 349: Iowa Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 350: Iowa Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 351: Iowa Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 352: Kansas Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 353: Kansas Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 354: Kansas Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 355: Kansas Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 356: Kansas Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Connected Patient Monitoring Devices Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Connected Patient Monitoring Devices Market, by Connectivity Technology, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Connected Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Connected Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Connected Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 372: U.S. Connected Patient Monitoring Devices Market: Competitive Landscape Snapshot, 2025
TABLE 373: U.S. Connected Patient Monitoring Devices Market: Key Company Market Share Analysis, 2025
TABLE 374: U.S. Connected Patient Monitoring Devices Market: Company Positioning Matrix
TABLE 375: U.S. Connected Patient Monitoring Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 376: U.S. Connected Patient Monitoring Devices Market: Connectivity and Interoperability Benchmarking
TABLE 377: U.S. Connected Patient Monitoring Devices Market: Hospital and Home Monitoring Presence Benchmarking
TABLE 378: U.S. Connected Patient Monitoring Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 379: GE HealthCare: Company Profile
TABLE 380: Philips Healthcare: Company Profile
TABLE 381: Medtronic: Company Profile
TABLE 382: Abbott Laboratories: Company Profile
TABLE 383: Masimo: Company Profile
TABLE 384: Baxter International and Hillrom: Company Profile
TABLE 385: Nihon Kohden: Company Profile
TABLE 386: Mindray North America: Company Profile
TABLE 387: Siemens Healthineers: Company Profile
TABLE 388: Edwards Lifesciences: Company Profile
TABLE 389: Boston Scientific Corporation: Company Profile
TABLE 390: ZOLL Medical Corporation: Company Profile
TABLE 391: Spacelabs Healthcare: Company Profile
TABLE 392: iRhythm Technologies: Company Profile
TABLE 393: DexCom: Company Profile
TABLE 394: ResMed: Company Profile
TABLE 395: OMRON Healthcare: Company Profile
TABLE 396: BioIntelliSense: Company Profile
TABLE 397: VitalConnect: Company Profile
TABLE 398: AliveCor: Company Profile
TABLE 399: Nonin Medical: Company Profile
TABLE 400: Withings Health Solutions: Company Profile
TABLE 401: Current Health, a Best Buy Health Company: Company Profile
TABLE 402: BIOTRONIK: Company Profile
TABLE 403: Vivalink: Company Profile
TABLE 404: U.S. Connected Patient Monitoring Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Connected Patient Monitoring Devices Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Connected Patient Monitoring Devices Market: Emerging Business Trends
TABLE 407: U.S. Connected Patient Monitoring Devices Market: Business Opportunities for Startups and Existing Players
TABLE 408: U.S. Connected Patient Monitoring Devices Market: Investment Prioritization Matrix
TABLE 409: U.S. Connected Patient Monitoring Devices Market: Technology Adoption Roadmap, 2026–2035
TABLE 410: U.S. Connected Patient Monitoring Devices Market: Future Hospital, Ambulatory and Home Monitoring Workflow Analysis
TABLE 411: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 412: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 413: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Physician Practices and Specialty Providers
TABLE 414: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Home Healthcare and Hospital-at-Home Providers
TABLE 415: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 416: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for Distributors, GPOs and Technology Integrators
TABLE 417: U.S. Connected Patient Monitoring Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 418: U.S. Connected Patient Monitoring Devices Market: Go-to-Market Strategy Considerations
TABLE 419: U.S. Connected Patient Monitoring Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 420: U.S. Connected Patient Monitoring Devices Market: Reimbursement and Evidence-Generation Strategy
TABLE 421: U.S. Connected Patient Monitoring Devices Market: Cybersecurity and Interoperability Strategy
TABLE 422: U.S. Connected Patient Monitoring Devices Market: Regional and State-Level Market Entry Prioritization
TABLE 423: U.S. Connected Patient Monitoring Devices Market: Scope Limitation
TABLE 424: U.S. Connected Patient Monitoring Devices Market: Data Use Limitation
TABLE 425: U.S. Connected Patient Monitoring Devices Market: Forecasting Limitation
TABLE 426: U.S. Connected Patient Monitoring Devices Market: Legal Disclaimer
TABLE 427: U.S. Connected Patient Monitoring Devices Market: Third-Party Data Disclaimer
TABLE 428: U.S. Connected Patient Monitoring Devices Market: Regulatory and Reimbursement Change Disclaimer
TABLE 429: U.S. Connected Patient Monitoring Devices Market: Technology and Cybersecurity Risk Disclaimer

List of Figures

FIGURE 1: U.S. Connected Patient Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem and Stakeholder Framework
FIGURE 4: Value Chain Analysis
FIGURE 5: Supply Chain Analysis
FIGURE 6: PESTEL Analysis
FIGURE 7: Porter’s Five Forces Analysis
FIGURE 8: Market Attractiveness Analysis
FIGURE 9: Market Dynamics
FIGURE 10: Innovation & Patent Landscape, 2021–2025
FIGURE 11: Clinical Workflow Economics Framework
FIGURE 12: Hospital Capital Procurement Decision Framework
FIGURE 13: Remote Monitoring Program Economics and ROI Framework
FIGURE 14: Alarm Management and Clinical Escalation Workflow
FIGURE 15: U.S. Connected Patient Monitoring Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 16: U.S. Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 17: U.S. Connected Patient Monitoring Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 18: Connected Monitoring Regulatory, Reimbursement and Cybersecurity Framework
FIGURE 19: EHR Interoperability and Connected Device Data Flow
FIGURE 20: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 21: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Networked Multiparameter and Bedside Monitoring Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Connected Cardiac and Rhythm Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Wearable Biosensors and Patch-Based Multiparameter Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Connected Glucose and Metabolic Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Connected Vital-Sign, Respiratory, Hemodynamic and Specialty Monitors Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Connectivity Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 28: Connectivity Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Wi-Fi and Enterprise Network-Connected Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Bluetooth and Smartphone-Connected Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Cellular-Enabled Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Proprietary Radiofrequency and Medical Telemetry Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Hybrid Gateway, Cloud and Edge-Connected Architectures Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Cardiovascular Disease and Hypertension Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Diabetes, Obesity and Metabolic Disease Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Respiratory Disease and Sleep-Related Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Post-Acute, Surgical, Oncology and Hospital-at-Home Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Maternal, Neonatal, Neurologic, Renal and Other Specialty Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 42: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Physician Practices and Specialty Clinics Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Ambulatory Surgery Centers and Outpatient Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Home Healthcare, Hospital-at-Home and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Skilled Nursing, Rehabilitation and Long-Term Care Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 49: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Distributor, Specialty Supplier and Technology Integrator Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Physician Practice, Home Monitoring and Program-Based Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 56: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Monitoring Infrastructure, Chronic Disease and Virtual Care Opportunity Map
FIGURE 58: West Region U.S. Connected Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 59: West Region Market Share Analysis by State, 2025
FIGURE 60: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: California Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Washington Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Arizona Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Colorado Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Oregon Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Utah Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Nevada Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Mexico Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Idaho Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Montana Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Wyoming Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Alaska Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Hawaii Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Northeast Region U.S. Connected Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 75: Northeast Region Market Share Analysis by State, 2025
FIGURE 76: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: New York Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Massachusetts Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: New Jersey Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Pennsylvania Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Connecticut Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Maine Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Vermont Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: New Hampshire Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Rhode Island Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Delaware Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: South Region U.S. Connected Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 88: South Region Market Share Analysis by State, 2025
FIGURE 89: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Texas Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Florida Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Georgia Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: North Carolina Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Tennessee Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: South Carolina Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Alabama Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Mississippi Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Louisiana Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Arkansas Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Kentucky Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Oklahoma Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Virginia Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Maryland Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: West Virginia Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Midwest Region U.S. Connected Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 106: Midwest Region Market Share Analysis by State, 2025
FIGURE 107: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Illinois Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Ohio Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Michigan Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Minnesota Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Indiana Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Wisconsin Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Missouri Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Iowa Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Kansas Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Nebraska Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: North Dakota Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: South Dakota Connected Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 121: Company Positioning Matrix
FIGURE 122: Key Player Product Portfolio Benchmarking
FIGURE 123: Connectivity and Interoperability Competitive Benchmarking
FIGURE 124: Hospital and Home Monitoring Presence Benchmarking
FIGURE 125: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 126: Connected Patient Monitoring Device Innovation Roadmap
FIGURE 127: AI-Based Deterioration Prediction Adoption Roadmap
FIGURE 128: Wearable Multiparameter Biosensor Opportunity Map
FIGURE 129: Hospital-at-Home Monitoring Growth Roadmap
FIGURE 130: Cellular and Hybrid Connectivity Adoption Roadmap
FIGURE 131: Future Market Scenario Analysis, 2026–2035
FIGURE 132: Disruptive Technologies Impact Matrix
FIGURE 133: Emerging Business Trends Matrix
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: Technology Adoption Roadmap, 2026–2035
FIGURE 136: Future Hospital, Ambulatory and Home Monitoring Workflow
FIGURE 137: Strategic Growth Roadmap for U.S. Connected Monitoring Device Companies
FIGURE 138: Go-to-Market Strategy Framework
FIGURE 139: Product Positioning and Portfolio Expansion Framework
FIGURE 140: Reimbursement and Evidence-Generation Strategy Framework
FIGURE 141: Cybersecurity and Interoperability Strategy Framework
FIGURE 142: Regional and State-Level Market Entry Prioritization Map
FIGURE 143: Report Scope and Disclaimer Framework